Australia: common questions

There is no blanket permission for psychedelic therapy. Prescription-only access since 2023. Exceptions, personal-use protections or reduced enforcement do not by themselves authorize treatment services.

Poisons Standard Schedule 8 (TGA Authorised Prescriber), Since 1 July 2023, specialist psychiatrists authorised under the TGA’s Authorised Prescriber scheme can access MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression. These remain unapproved medicines. Clinical-trial access is also possible; this is not general legal access or a retreat-licensing scheme.

Only authorized psychiatrists may prescribe Limited to PTSD (MDMA) and treatment-resistant depression (psilocybin) Treatment happens in clinical settings, not retreats Possession without a prescription remains a crime

We don't have a licensing authority on record for listed providers here.

2 listed; 0 with a license confirmed against an official registry.

MDMA- and psilocybin-assisted therapy (TGA Authorised Prescriber pathway), Assisted psychotherapy for PTSD and treatment-resistant depression.

No stage-specific remote arrangement is documented in these listings. 0 unique listings have a remote-service or support record. Unknown arrangements are not evidence that remote support is unavailable. Preparation and integration are separate from administration; these records do not establish legal permission or clinical eligibility for remote treatment.

No. Laws change often, confirm with the official sources below or a licensed attorney.